Preventive Effect of Controlled-Release Dexamethasone on Cochlear Ossification in Meningitis Model

Area of Science:

• Otolaryngology
• Neurology
• Pharmacology

Background:

• Pneumococcal meningitis causes significant mortality and morbidity despite treatment.
• Inflammatory responses post-meningitis can lead to cochlear fibrosis and ossification, complicating cochlear implant surgery.

Purpose of the Study:

• To investigate the preventive effect of controlled-release dexamethasone implants on cochlear structural integrity following pneumococcal meningitis.

Main Methods:

• Twenty-four rats with induced pneumococcal meningitis were divided into study (dexamethasone implant) and control groups.
• Implants were placed transbullarly into the round window; cochleas were examined histologically after 3 months.

Main Results:

• Pneumococcal meningitis induced significant fibrosis and ossification, particularly in the basal turn of the cochlea.
• The dexamethasone implant group exhibited reduced fibrosis across all cochlear turns and less ossification in the basal turn compared to controls.

Conclusions:

• Pneumococcal meningitis leads to pronounced basal turn cochlear damage.
• Controlled-release dexamethasone implants demonstrate efficacy in preventing cochlear ossification and fibrosis.
• These implants may play a role in mitigating post-meningitic hearing loss and facilitating cochlear implant procedures.